MedTrace Logo

"Platelet Rich Plasma for the Management of Post-Viral Olfactory Dysfunction.

NCT05666492 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-12-27

No results posted yet for this study

Summary

SARS COV-19 has resulted in prolonged olfactory dysfunction in many patients. The investigators aim to compare the effect of topical platelet-rich plasma (test) vs saline (placebo) in patients with covid-related post-viral olfactory dysfunction.

Conditions

  • Olfactory Disorder
  • Olfaction Disorders

Interventions

OTHER

Platelet rich plasma

Platelet-rich plasma will be placed on the olfactory epithelium topically.

OTHER

Saline

Saline will be placed on the olfactory epithelium topically.

Sponsors & Collaborators

  • Monell Chemical Senses Center

    collaborator OTHER

  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • David Rosen, MD · Thomas Jefferson University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-17
Primary Completion
2024-08-17
Completion
2024-08-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05666492 on ClinicalTrials.gov